Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial"

Arianne C. van Bon; J. Hans DeVries

doi:10.1089/dia.2011.0132

Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial"

Arianne C. van Bon
, J. Hans DeVries

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	871
Journal	Diabetes technology & therapeutics
Volume	13
Issue number	8
DOIs	https://doi.org/10.1089/dia.2011.0132
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1089/dia.2011.0132

Cite this

@article{ae993098ed454ae1945a33b8b09f5677,

title = "Response to Jovanovic for the Comments on Our Study {"}Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial{"}",

author = "\{van Bon\}, \{Arianne C.\} and DeVries, \{J. Hans\}",

year = "2011",

doi = "10.1089/dia.2011.0132",

language = "English",

volume = "13",

pages = "871",

journal = "Diabetes technology \& therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "8",

}

van Bon, AC & DeVries, JH 2011, 'Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial"', Diabetes technology & therapeutics, vol. 13, no. 8, pp. 871. https://doi.org/10.1089/dia.2011.0132

Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial". / van Bon, Arianne C.; DeVries, J. Hans.
In: Diabetes technology & therapeutics, Vol. 13, No. 8, 2011, p. 871.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial"

AU - van Bon, Arianne C.

AU - DeVries, J. Hans

PY - 2011

Y1 - 2011

U2 - 10.1089/dia.2011.0132

DO - 10.1089/dia.2011.0132

M3 - Comment/Letter to the editor

SN - 1520-9156

VL - 13

SP - 871

JO - Diabetes technology & therapeutics

JF - Diabetes technology & therapeutics

IS - 8

ER -